Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 64Breast Neoplasms 15Urinary Bladder Neoplasms 12Colorectal Neoplasms 9Carcinoma, Renal Cell 8Kidney Neoplasms 7Lung Neoplasms 6Neoplasm Metastasis 4Gastrointestinal Neoplasms 4Testicular Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Urogenital Neoplasms 2Urinary Incontinence 2Head and Neck Neoplasms 2Erectile Dysfunction 2Disease 2Depression 2Carcinoma, Transitional Cell 2Anxiety Disorders 2Adenocarcinoma 2Wilms Tumor 1Vomiting 1Varicocele 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Abnormalities 1Urinary Bladder, Overactive 1Thyroid Neoplasms 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1Genetic Testing 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Genitourinary × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡